Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41598-019-44588-3
DC FieldValue
dc.titleRobust and accurate detection and sizing of repeats within the DMPK gene using a novel TP-PCR test
dc.contributor.authorLeferink, M.
dc.contributor.authorWong, D.P.W.
dc.contributor.authorCai, S.
dc.contributor.authorYeo, M.
dc.contributor.authorHo, J.
dc.contributor.authorLian, M.
dc.contributor.authorKamsteeg, E.-J.
dc.contributor.authorChong, S.S.
dc.contributor.authorHaer-Wigman, L.
dc.contributor.authorGuan, M.
dc.date.accessioned2021-12-28T10:01:07Z
dc.date.available2021-12-28T10:01:07Z
dc.date.issued2019
dc.identifier.citationLeferink, M., Wong, D.P.W., Cai, S., Yeo, M., Ho, J., Lian, M., Kamsteeg, E.-J., Chong, S.S., Haer-Wigman, L., Guan, M. (2019). Robust and accurate detection and sizing of repeats within the DMPK gene using a novel TP-PCR test. Scientific Reports 9 (1) : 8280. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-019-44588-3
dc.identifier.issn2045-2322
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/212102
dc.description.abstractMyotonic dystrophy type 1 is a multisystem disorder caused by the expansion of a trinucleotide repeat in the DMPK gene. In this study we evaluated the performance of the FastDM1TMDMPK sizing kit in myotonic dystrophy type 1 testing. This commercially available triplet repeat-primed PCR based kit was validated using reference and clinical samples. Based on testing with 19 reference samples, the assay yielded repeat sizes within three repeats from the consensus reference length, demonstrating an accuracy of 100%. Additionally, the assay generated consistent repeat size information with a concentration range of template-DNA, and upon repetition and reproduction (CV 0.36% to 0.41%). Clinical performance was established with 235 archived prenatal and postnatal clinical samples, yielding results of 100% sensitivity (95% CI, 97.29% to 100%) and 100% specificity (95% CI, 96.19% to 100%) in classifying the samples into the respective genotype groups of 5–35 (normal), 36–50 (non-pathogenic pre-expansion), 51–150 (unstable intermediate-sized pathogenic) or >150 (unstable pathogenic) CTG repeats, respectively. Furthermore, the assay identified interrupted repeat expansions in all samples known to have interruptions, and also identified interruptions in a subset of the clinical samples. © 2019, The Author(s).
dc.publisherNature Publishing Group
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2019
dc.typeArticle
dc.contributor.departmentDEPT OF PAEDIATRICS
dc.contributor.departmentINSTITUTE OF MOLECULAR & CELL BIOLOGY
dc.description.doi10.1038/s41598-019-44588-3
dc.description.sourcetitleScientific Reports
dc.description.volume9
dc.description.issue1
dc.description.page8280
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-019-44588-3.pdf1.71 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

4
checked on Feb 3, 2023

Page view(s)

89
checked on Feb 2, 2023

Download(s)

2
checked on Feb 2, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons